Literature DB >> 9802943

Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins.

M Reichlin1.   

Abstract

Antibodies to dsDNA and ribosomal P proteins are disease specific for systemic lupus erythematosus (SLE) and vary with disease activity. It is thought that antibodies to dsDNA are involved in the pathogenesis of lupus nephritis and clinical data consistent with that hypothesis also exist for anti-ribosomal P antibodies; these two specific antibodies both bind and penetrate cells in culture. In the case of anti-P antibodies, the cellular receptor appears to be a membrane form of the Po 38 kDa phosphoprotein, which is present on several cell types and appears to mediate the binding and penetration of anti-P antibodies which then localize in the cytoplasm. In the case of anti-dsDNA, numerous cellular receptors exist on various cell types which may account for the three types of behavior demonstrated by antibodies towards dsDNA. These include (a) localization and prolonged residence on the membrane, with prompt cytolysis upon addition of hemolytic complement, (b) penetration and cytoplasmic localization and (c) penetration and nuclear localization. Both anti-P and anti-dsDNA are potent inhibitors of protein synthesis and are likely to mediate cellular dysfunction via this pathway. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802943     DOI: 10.1006/jaut.1998.0219

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  17 in total

Review 1.  Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Simona D'Amore; Massimo D'Amore
Journal:  Clin Exp Med       Date:  2010-05-09       Impact factor: 3.984

2.  Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy.

Authors:  Hua Xiao; Min Wang; Yimei Du; Jing Yuan; Guanghong Zhao; Danna Tu; Yu-Hua Liao
Journal:  Heart Vessels       Date:  2011-08-04       Impact factor: 2.037

Review 3.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

4.  The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells.

Authors:  G Tezel; M B Wax
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

5.  Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.

Authors:  Abdullah Almamy; Christian Schwerk; Horst Schroten; Hiroshi Ishikawa; Abdul Rahman Asif; Bernhard Reuss
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

6.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

7.  Immunological Aspects of Age-Related Macular Degeneration.

Authors:  Michael J Allingham; Anna Loksztejn; Scott W Cousins; Priyatham S Mettu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units?

Authors:  Lumme Kadaja; Kai E Kisand; Nadezhda Peet; Urmo Braun; Kaja Metsküla; Kaupo Teesalu; Riina Vibo; Kalle V Kisand; Raivo Uibo; Harald Jockusch; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

9.  Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.

Authors:  Fidan Barkhudarova; Cornelia Dähnrich; Anke Rosemann; Udo Schneider; Winfried Stöcker; Gerd-Rüdiger Burmester; Karl Egerer; Wolfgang Schlumberger; Falk Hiepe; Robert Biesen
Journal:  Arthritis Res Ther       Date:  2011-02-10       Impact factor: 5.156

Review 10.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.